Le marché des échantillons de tissus congelés devrait atteindre 105 045,91 000 USD d'ici 2028 contre 44 399,07 070 USD en 2021. Le marché devrait croître à un TCAC de 13,1 % au cours de la période 2021-2028.
Les échantillons de tissus congelés sont préférés dans les analyses telles que le séquençage de nouvelle génération, le transfert Western pour les modifications protéiques post-traductionnelles, la spectrométrie de masse et la réaction en chaîne par polymérase quantitative en temps réel. Les échantillons de tissus congelés sont l'étalon-or pour le séquençage de l'ADN et de l'ARN, en particulier lorsque les brins doivent être plus longs que 50 paires. Les échantillons de tissus congelés sont également utiles en immunohistochimie car les protéines sont toujours conservées dans leur état natif.
Perspectives stratégiques
La croissance du marché mondial des échantillons de tissus congelés est attribuée à la hausse l'application d'échantillons de tissus congelés dans divers domaines de recherche et thérapeutiques et l'utilisation croissante d'échantillons de tissus congelés en raison de la prévalence croissante du cancer. Cependant, le risque associé à la préservation et à la conservation des échantillons de tissus congelés entrave dans une certaine mesure la croissance du marché mondial des échantillons de tissus congelés.
Régions lucratives sur le marché des échantillons de tissus congelés< /h3>
Application croissante d'échantillons de tissus congelés en raison de la prévalence croissante du cancer
Application croissante d'échantillons de tissus congelés en raison de la prévalence croissante du cancer
Selon les données publiées par Cancer Research UK en 2020, environ 0,16 million de personnes au Royaume-Uni meurent chaque année des suites d'un cancer. De plus, selon le rapport Globocan, en 2020, le cancer du sein féminin a dépassé le cancer du poumon en tant que cancer le plus diagnostiqué, avec environ 2,3 millions de nouveaux cas (11,7 %), suivi du poumon (11,4 %), colorectal (10,0 %), de la prostate (7,3 %) et de l'estomac (5,6 %). Le cancer du poumon est resté la principale cause de décès par cancer, avec environ 1,8 million de décès (18 %), suivi des cancers colorectaux (9,4 %), du foie (8,3 %), de l'estomac (7,7 %) et du sein chez la femme (6,9 %). L'incidence globale était 2 à 3 fois plus élevée dans les pays en transition que dans les pays en transition. Cependant, les décès par cancer du sein et du col de l'utérus chez les femmes étaient considérablement plus élevés dans les pays en transition que dans les pays en transition. Une prévalence aussi élevée de cancer entraîne le besoin d'échantillons de tissus congelés pour la recherche et l'étude. Les études de plus en plus nombreuses utilisant des échantillons de tissus tumoraux congelés établissent plusieurs champs de diagnostic et de traitement pour cette affection chronique. Par conséquent, l'incidence croissante du cancer dans le monde alimente la croissance du marché des échantillons de tissus congelés. De plus, au Canada, le cancer est la principale cause de décès au sein de la population et il est considéré comme la deuxième cause après les maladies cardiaques aux États-Unis. Selon l'American Cancer Society, environ 1,9 million de nouveaux cas de cancer sont diagnostiqués et 609 360 décès aux États-Unis sont estimés en 2022. Les cancers de la prostate sont les cancers les plus fréquemment diagnostiqués chez les hommes en Amérique du Nord ; cependant, les cancers du sein restent en tête chez les femmes. De plus, le cancer du poumon demeure la cause de décès la plus fréquente dans la population. On estime que le nombre de nouveaux cas d'incidence du cancer est de 439,2 pour 100 000 hommes et femmes par an. Par conséquent, la prévalence croissante du cancer dans la population entraîne la croissance du marché des échantillons de tissus congelés dans le monde entier.
Informations sur les produits
Le marché mondial des échantillons de tissus congelés, basé sur le produit, est segmenté en échantillons de tissus normaux congelés, échantillons de tissus tumoraux congelés et échantillons de tissus malades congelés. Le segment des échantillons de tumeurs de tissus congelés détenait la plus grande part du marché en 2021. De plus, le même segment devrait enregistrer le TCAC le plus élevé sur le marché des échantillons de tissus congelés au cours de la période de prévision de 2021 à 2028. La croissance est principalement attribuée à augmentation des cas de tumeurs dans le monde.
Marché des échantillons de tissus congelés, par produit 2021 et 2028
Informations basées sur les applications
Sur la base des applications, le marché mondial des échantillons de tissus congelés est segmenté en diagnostic et traitement des maladies, recherche sur le cancer et d'autres maladies et analyse morphologique. En 2021, le segment de la recherche sur le cancer et d'autres maladies représentait la plus grande part du marché mondial des échantillons de tissus congelés. Cependant, le segment du diagnostic et du traitement des maladies devrait croître au TCAC le plus rapide de 13,8 % de 2021 à 2028.
Informations basées sur l'utilisateur final
< CONSEIL>
Le marché mondial des échantillons de tissus congelés, basé sur l'utilisateur final, est segmenté en instituts universitaires et de recherche, hôpitaux et cliniques, centres de diagnostic, etc. En 2021, le segment des instituts universitaires et de recherche détenait la plus grande part du marché mondial des échantillons de tissus congelés. Cependant, le segment des hôpitaux et des cliniques devrait croître au TCAC le plus rapide de 13,9 % de 2021 à 2028.
Les lancements et les approbations de produits sont des stratégies couramment adoptées par les entreprises pour étendre leur présence mondiale empreintes et portefeuilles de produits. De plus, les acteurs du marché des échantillons de tissus congelés se concentrent sur la stratégie de partenariat pour élargir leur clientèle, ce qui, à son tour, leur permet de maintenir leur marque à l'échelle mondiale. Le marché mondial des échantillons de tissus congelés devrait prospérer avec le développement de nouveaux produits innovants par les acteurs du marché.
Profils des entreprises
- < CONSEIL>
- Audubon Bioscience Co
- REPROCELL Inc.
- Bay Biosciences LLC
- US Biolab Corporation, Inc< /li>
- AMS Biotechnology (Europe) Ltd.
- Généticien, Inc
- ZenBio, Inc
- BioChain Institute Inc
- ProteoGenex, Inc.
< li>OriGene Technologies, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Frozen tissue samples are biospecimens preferred in analyses such as next-generation sequencing, western blotting for post-translational protein modifications, mass spectrometry, and quantitative real-time polymerase chain reaction. Frozen tissue samples are the gold standard for DNA and RNA sequencing, especially when the strands must be longer than 50 pairs. In immunohistochemistry, frozen tissue samples are also useful as the proteins are still preserved in their native state.
The factors that are driving the growth of the market are rising application of frozen tissue samples in various research and therapeutic areas and risk associated with preservation and maintenance of frozen tissues samples. Moreover, the proliferation of biotechnology industry in developing regions provide growth opportunities to the frozen tissues samples market and developments in frozen tissue samples is expected to be a future trend that will drive the market’s growth in the coming years.
The frozen tissue tumor samples segment was likely to hold the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period of 2021 to 2028. The growth is mainly attributed due to increasing tumor cases globally.
In 2021, the academic and research institutes segment was likely to hold the largest share of the market. However, the hospitals and clinics segment is expected to witness growth in its demand at the fastest CAGR of 13.8% during 2021 to 2028.
The global Frozen Tissues Samples market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. Increasing incidence of cancer, growing need for diagnosing cancer, increasing competition between the market player, high R&D spending, and government grants for research institutes to develop new diagnosing methods are some of the prominent factors propelling the market growth in North America. Moreover, owing to the growing investments from international players in China and India. Aging population coupled with increasing demand for advanced medical technologies are expected to accelerate growth of the frozen tissues samples Market in Asia Pacific region.
The Frozen Tissues Samples market majorly consists of the players such as Audubon Bioscience Co; REPROCELL Inc.; Bay Biosciences LLC; US Biolab Corporation, Inc; AMS Biotechnology (Europe) Ltd.; Geneticist, Inc.; ZenBio, Inc.; OriGene Technologies, Inc.; BioChain Institute Inc.; and ProteoGenex, Inc., among others.
The List of Companies - Frozen Tissues Samples Market
- Audubon Bioscience Co
- REPROCELL Inc.
- Bay Biosciences LLC
- US Biolab Corporation, Inc.
- AMS Biotechnology (Europe) Ltd.
- Geneticist, Inc.
- ZenBio, Inc.
- OriGene Technologies, Inc.
- BioChain Institute Inc.
- ProteoGenex, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)